Doak Dermatologics, a subsidiary of Bradley Pharmaceuticals, Inc., announced the introduction of prescription-only Rosula[R] Lotion for the topical treatment of acne and rosacea. Rosula Lotion combines the beneficial keratolytic moisturizer, urea, with two respected acne/rosacea therapies-sodium sulfacetamide and sulfur. Taking acne/rosacea therapy to the next level, Doak offers patients the benefits of antibacterial, keratolytic, moisturizing agents in a pleasant-smelling, non-drying, alcohol-free formation. Urea provides the "missing piece" of acne/rosacea therapy which represents a marked departure from traditional therapies to position Rosula[R] ...